Significant clinical benefit of first-line palliative chemotherapy in advanced soft-tissue sarcomaRetrospective analysis and identification of prognostic factors in 488 patients
Vasilios Karavasilis, MD 1, Beatrice M. Seddon, MD, FRCR, PhD 2, Susan Ashley, BSc, PhD 1, Omar Al-Muderis, BSc 1, Cyril Fisher, MD, FRCPath 1, Ian Judson, MD, FRCP 1 *
1Royal Marsden Hospital, London, England, United Kingdom
2University College Hospital, London, England, United Kingdom